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A defi  ning feature of the adaptive immune sys-
tem is the capacity to “remember” past encoun-
ters with a pathogen and subsequently mount 
superior responses (recall responses) to a second-
ary challenge with the same, or related, patho-
gen (1). In the case of infl  uenza and parainfl  uenza 
virus infections, it has been established that 
antigen-specifi  c CD8+ T cells elicited during 
a primary infection persist at high frequencies 
for years after clearance of the virus (2–4). These 
memory CD8+ T cells are able to mediate recall 
responses that result in accelerated viral clear-
ance and survival after challenge with an other-
wise lethal dose of virus (5, 6). The enhanced 
responsiveness of antigen-specifi  c memory CD8+ 
T cells as compared with naive CD8+ T cells is 
due to increased cell numbers, higher activation 
status, reduced stimulatory requirements, more 
rapid acquisition of eff  ector functions, and altered 
homing patterns (1, 7, 8).
Memory CD8+ T cells are heterogeneous 
in terms of phenotype, function, and anatomi-
cal distribution. This heterogeneity is thought 
to refl  ect the diff  erent functional characteristics 
and migratory properties of memory CD8+ 
T cell subsets and has led to the paradigm that 
memory cells can be divided into two major 
subsets: central– and eff  ector–memory T cells 
(2, 3, 6, 9–15). Central–memory T cells ex-
press high levels of CD62L and CCR7, which 
directs them to enter high endothelial venules 
and thereby localize predominantly in second-
ary lymphoid tissues. Eff  ector–memory T cells 
express low levels of CD62L and CCR7 and 
tend to localize predominantly in nonlymphoid 
and peripheral tissues (15, 16). The diff  erent 
characteristics of central– and eff  ector–memory 
CD8+ T cells suggest that these cells play dif-
ferent roles in recall responses. However, the 
relative contributions of each subpopulation 
to the accumulation of fully activated eff  ector 
cells during a recall response after secondary in-
fection are unclear (17–19). One possibility is 
that eff  ector–memory T cells that accumulate 
in peripheral sites such as the lung mediate 
early and nonsustained responses to the patho-
genic challenge, whereas central–memory cells 
in secondary lymphoid organs mediate a late 
but sustained proliferative response to the chal-
lenge (20). However, studies on the capacities 
of eff  ector– and central–memory cell subpopu-
lations to mediate recall responses in vivo have 
been contradictory. Several groups have shown 
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that central–memory T cells dominate recall responses to 
pathogens that mediate systemic infections, although this 
does not necessarily correlate with protective effi   cacy (16, 
21–25). Conversely, other studies have shown that eff  ector–
memory CD8+ T cells can contribute equally to, or even 
dominate, recall responses (26, 27). We have used a dual 
adoptive transfer system in which the relative contributions 
of Sendai virus–specifi  c eff  ector– and central–memory cells 
to recall responses in the lung could be directly compared on 
a per-cell basis. These studies demonstrated that the relative 
contribution of eff  ector– and central–memory cells to the 
recall response in the lung varied depending on how re-
cently memory had been established (28, 29). Although ef-
fector–memory CD8+ T cells dominated the recall response 
relatively soon after infection (up to 6 mo after infection), 
central–memory CD8+ T cells dominated the recall response 
at later times (12 mo after infection). Furthermore, the data 
showed that on a per-cell basis, both central– and eff  ector–
memory T cells isolated from the spleens of mice 1 yr after 
infection mediated dramatically stronger recall responses 
to Sendai virus infection than the same subpopulations of 
memory T cells isolated 1 mo after infection (28). The over-
all conclusion from these and other studies is that there is 
no direct or generalized relationship between central– and 
eff  ector–memory phenotype of the memory T cell pool and 
the ultimate composition of the recall response at the site 
of infection.
Here, we defi  ne three distinct subpopulations of memory 
CD8+ T cells that are superior to central– and eff  ector–memory 
phenotype in predicting recall effi   cacy. The data resolve dis-
crepancies regarding the contribution of central– and eff  ector–
memory T cells to recall responses and suggest an alternative 
or additional scheme to classify memory T cells. The fi  ndings 
extend our understanding of how recall responses are gener-
ated and indicate which types of memory T cells should be tar-
geted by vaccines.
RESULTS
Activation markers identify distinct memory 
CD8+ T cell subsets
Studies addressing the contribution of central– and eff  ector–
memory CD8+ T cell subpopulations to the recall response 
have been contradictory and inconclusive (16, 21–24, 26, 28). 
Figure 1.  Memory CD8+ T cells can be divided into three major 
subsets. (A) Splenocytes isolated at various times after infection were 
stained with Sendai NP324–332/Kb tetramer and monoclonal antibodies. The 
profi  les are gated on tetramer+/CD8+ cells, and the numbers indicate the 
percentage of gated cells in each quadrant. Data are representative of six 
individual mice at 1 and 6 mo after infection, and three individual mice at 
12 and 24 mo after infection. (B) Splenocytes isolated 1 mo after Sendai 
infection were stained as described in A and gated on tetramer+/CD8+cells. 
The top plot depicts the CD127 × CD43 profi  le of tetramer+ cells, and 
the roman numerals correspond to the expression of CD27 (shown in the 
histograms below) within the indicated quadrant. (C) Splenocytes isolated 
1 mo after Sendai virus infection were stained as described for A and gated 
on tetramer+/CD8+ cells. CXCR3 × CD43 profi  les were then determined on 
either CD62Llo or CD62Lhi cells. Data are from the same staining experiment 
as in A. (D) Splenocytes isolated 1 mo after Sendai virus infection were 
stained with NP324–332/Kb tetramer and monoclonal antibodies. Data show 
the percentage of KLRG1+ or PD1+ cells among tetramer+/CD8+ cells that 
had been subgated into CD27hi/CD43lo, CD27hi/CD43hi, and CD27lo/CD43lo 
subpopulations. (E) Splenocytes isolated 1 mo after intranasal x31 infl  uenza 
virus infection were stained with either Flu NP366–374/Db tetramer or Flu 
PA224-233/Db tetramer and monoclonal antibodies as described in A. The 
data in each subpanel are gated on either Flu NP366–374/Db tetramer+/CD8+ 
cells (top) or Flu PA224–233/Db tetramer+/CD8+ cells (bottom), and the 
  numbers represent the percentage of cells in each quadrant. The data are 
representative of three independent experiments.JEM VOL. 204, July 9, 2007  1627
ARTICLE
Therefore, we speculated that recall effi   cacy correlated with 
other characteristics of memory cells that were indepen-
dent of their central– or eff  ector–memory status. To test 
this notion, we analyzed the phenotype of memory CD8+ 
T cells generated by intranasal Sendai virus infection (spe-
cifi  c for the immunodominant NP324–332/Kb epitope) with 
a particular emphasis on the expression of markers that dis-
tinguish quiescent and semi-activated memory T cell sub-
sets, such as CD27, CD43 (activated isoform), and CD127 
(30–33). As shown in Fig. 1, analyses of CD27 and CD43 
(1B11) expression at 1 mo after Sendai virus infection divided 
NP324–332/Kb-specifi  c T cells into three distinct subpopula-
tions: CD27hi/CD43hi, CD27hi/CD43lo, and CD27lo/CD43lo. 
Further analysis revealed that the chemokine receptor CXCR3 
was coordinately expressed with CD27 (not depicted) 
and that the same three subpopulations of memory CD8+ 
T cells could also be defi  ned by CXCR3/CD43 expression 
(Fig. 1 A). There was also a similar pattern of expression for 
CD127 in that all of the CD127+ cells were also CD27+. 
The correlation between CD127 and CD27 is illustrated in 
Fig. 1 B. Analysis of the three coordinated memory T cell 
subsets at various times after infection revealed that the 
CD27hi/CD43lo subpopulation progressively dominated the 
memory T cell pool, representing  90% of the antigen-
specifi  c T cells detected at 2 yr after infection (Fig. 1 A). 
In contrast, the CD27lo/CD43lo subpopulation progressively 
declines and disappeared by about 1 yr after infection. Thus, 
the representation of these distinct subpopulations within 
the total memory CD8+ T cell pool progressively changes 
over time.
The identifi  cation of three distinct memory populations 
expressing coordinated patterns of markers was of interest be-
cause very few markers are coordinately expressed on memory 
T cells. One question was whether these subpopulations cor-
responded to the central– (CD62Lhi) and eff  ector– (CD62Llo) 
memory CD8+ T cells subsets. Consistent with previous 
reports (3, 28),  10% of Sendai virus NP324–332/Kb-specifi  c 
memory CD8+ T cells expressed a central–memory (CD62Lhi) 
phenotype at 1 mo after infection, and this percentage rose 
to 90% at 12 mo after infection. Regardless of the time point, 
both central– and eff  ector–memory CD8+ T cells were pre-
sent in roughly equal frequencies in each of the subpopulations 
(CXCR3hi/CD43hi, CXCR3hi/CD43lo, and CXCR3lo/
CD43lo; Fig. 1 C). Collectively, the data indicate that the di-
vision of memory CD8+ T cells into three major subpopula-
tions is independent of central– or eff  ector–memory status.
To determine whether these subpopulations of memory 
T cells expressed markers typically associated with T cell senes-
cence or exhaustion, we analyzed the expression of killer cell 
lectin-like receptor G1 (KLRG1), a marker of senescent cells 
linked to poor in vitro proliferative capacity, and programmed 
death-1 (PD-1), a marker of T cell exhaustion (34–36). As 
shown in Fig. 1 D,  40% of the CD27lo/CD43lo cells expressed 
KLRG1, whereas none of the cells expressed PD-1. The data 
suggest that the CD27lo/CD43lo population may include cells 
that have the characteristics of immune senescence.
The three memory cell subpopulations (CD27hi/CD43hi, 
CD27hi/CD43lo, and CD27lo/CD43lo) were not a unique 
feature of Sendai virus or a mucosal route of infection. As 
shown in Fig. 1 E, identical subpopulations were also identi-
fi  ed in the pool of memory CD8+ T cells elicited by intra-
nasal infl  uenza virus infection (specifi  c for both the infl  uenza 
NP366–374/Db and PA224–233/Db epitopes). The same subpop-
ulations of memory CD8+ T cells were also observed after 
intraperitoneal (systemic) Sendai and infl  uenza virus infection 
(not depicted).
We next asked whether the rate of homeostatic turnover 
diff  ered for each of the three memory cell subpopulations 
(CD27hi/CD43hi, CD27hi/CD43lo, and CD27lo/CD43lo; 
references 37 and 38). Mice were intranasally infected with 
Sendai virus and 1 mo later were administered BrdU for 14 d 
in the drinking water. Memory T cells in each of the sub 
populations became BrdU+ over this timeframe, indicating 
that all subpopulations were being maintained to some extent 
by homeostatic proliferation (Fig. 2). However, the rate of 
BrdU accumulation was markedly diff  erent for each of the 
Figure 2.  Memory CD8+ T cell subpopulations homeostatically 
proliferate at different rates. Mice (1 mo after Sendai virus infection) 
were administered BrdU in the drinking water for 14 d. Splenocytes 
were then stained with Sendai NP324–332/Kb tetramer and monoclonal 
 antibodies. The cells were gated first on tetramer+/CD8+ cells and 
then subgated into CXCR3hi/CD43lo, CXCR3hi/CD43hi, and CXCR3lo/CD43lo 
subpopulations (as indicated by the fl  ow cytometric plot and schematic 
diagram, top panels). The frequency of BrdU+ cells was then determined 
in each subpopulation. The bar chart shows the percentage of BrdU+ 
cells in total tetramer+/CD8+ cells (pen bars) or in tetramer+/CD8+ cells 
gated on each of the memory T cell subpopulations based on either 
CD27×CD43 expression, CXCR3×CD43 expression, or CD127×CD43 
expression (shaded bars use the same schematic indicated in the top right 
of the fi  gure). The values are means ± SD of three individual mice and are 
representative of three independent experiments.1628  RECALL EFFICACY OF MEMORY CD8 T CELLS | Hikono et al.
three subpopulations. For example, the CXCR3lo/CD43lo 
subpopulation accumulated BrdU at one quarter the rate of 
the CXCR3hi/CD43hi subpopulation. The slower turnover 
rate of the CXCR3lo/CD43lo subpopulation may account for 
the progressive disappearance of this population from the 
memory T cell pool over time. The same patterns of homeo-
static proliferation were observed when the three subpopula-
tions were identifi  ed on the basis of CD27 (consistent with 
the coordinate expression of this marker with CXCR3) and 
CD127 (Fig. 2).
We also analyzed the eff  ector functions of the diff  erent 
memory T cell subpopulations. All of the tetramer+ cells in 
each subpopulation were functional in terms of the capacity 
to secrete IFN-γ in an intracellular cytokine assay, consis-
tent with previous studies showing that the entire NP324–332/
Kb-specifi  c CD8+ memory T cell population is functional 
in terms of IFN-γ secretion (reference 3 and not depicted). 
In addition, the fraction of IFN-γ+ cells that produced 
TNF-α and IL-2 was similar for each subpopulation, al-
though the frequency of IL-2+ cells was highest among the 
CD27hi/CD43lo subpopulation (Fig. 3 A). In contrast, there 
was a notable diff  erence in granzyme B expression among 
the three memory T cell subpopulations. Although the 
CD27hi/CD43hi and CD27hi/CD43lo cells were granzyme 
B−, the CD27lo/CD43lo cells were granzyme B+ (Fig. 3 B). 
However, granzyme B was expressed by all three subpopu-
lations in the context of a recall response to Sendai virus 
infection (Fig. 3 C).
Memory CD8+ T cell subpopulations differ 
in recall effi  cacy in the lung
CD8+ T cell recall responses to secondary respiratory virus 
infections are characterized by an increased accumulation of 
activated eff  ector CD8+ T cells within the lungs and lung 
airways. To determine the individual contributions of the 
diff  erent memory T cell subpopulations to the accumula-
tion of these cells in the lungs, we used a dual adoptive 
transfer approach in which we could directly compare the 
responses of two separate populations of memory T cells in 
the same animal under the same infection conditions (28, 29). 
Initial experiments were focused on memory T cells that 
were either positive or negative for CD43 expression. Spleen 
cells from C57BL/6 and B6-CD45.1 donors were en-
riched for CD8+ cells on a negative selection column and 
Figure 3.  Memory CD8+ T cell subpopulations display similar 
effector functions after antigen challenge. (A) Splenic memory CD8+ 
T cells from C57BL/6 mice were isolated 1 mo after infection and fl  ow cyto-
metrically sorted into subpopulations based on activation marker expres-
sion (CD27hi/CD43lo, CD27hi/CD43hi, and CD27lo/CD43lo). Aliquots of the 
sorted cells were stained with Sendai NP324–332/Kb tetramer to determine 
the frequency of antigen-specifi  c cells within each subset. Sorted popula-
tions were co-cultured with CD45.1+ splenocytes pulsed with 1 μg 
Sendai NP324–332 peptide for 5 h in the presence of brefeldin A, and IFN-γ, 
TNF-α, and IL-2 were measured by intracellular staining and fl  ow cytometry. 
The data are plotted as the frequency of cytokine+ cells and normalized 
to IFN-γ expression. The data are derived from three independent ex-
periments for each subpopulation. (B) Splenocytes from resting Sendai 
memory mice were divided into memory CD8+ subpopulations by staining 
with Sendai NP324–332/Kb tetramer, CD27, and CD43 (top), and granzyme B 
expression was measured in each subpopulation as denoted by roman 
numerals (bottom). In each of the bottom panels, granzyme B expression 
is denoted by the open histogram, and isotype control staining is shown 
by the shaded histogram. The data are representative of two independent 
experiments. (C) Splenic memory CD8+ T cell subsets were isolated from 
C57BL/6 by cell sorting as described above, and the number of Sendai-
specifi  c cells within each subpopulation was determined by staining with 
Sendai NP324–332/Kb tetramer. 3,000–5,000 Sendai-specifi  c cells from each 
subpopulation were transferred intravenously into individual naive CD90.1+ 
recipient mice, and the recipient mice were infected with 250 EID50 
Sendai virus 24 h later. Bronchoalveolar lavage, lung parenchyma, and 
spleen were harvested 11 d after infection, and granzyme B expression 
was measured in Sendai-specifi  c donor cells. The histograms shown are 
gated on Sendai NP324–332/Kb+ CD90.2+ donor cells, with granzyme B 
  expression denoted by the open histogram and isotype control staining 
denoted by the shaded histogram. The phenotype of the sorted memory 
donor subpopulations transferred is listed at the top of each column. The 
data are representative of two independent experiments, with three 
recipient mice for each memory subset.JEM VOL. 204, July 9, 2007  1629
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fl  ow cytometrically sorted on the basis of CD44 and CD43 
expression. The CD44hi/CD43hi and CD44hi/CD43lo sub-
population from each donor was then mixed together, such 
that the ratio of NP324–332/Kb cells was 1:1, and intrave-
nously injected into B6-CD90.1 recipient mice. 1 d later, 
recipient mice were intranasally infected with Sendai vi-
rus, and NP324–332/Kb-specifi  c T cells were analyzed 11 d 
later in the lung airways (bronchoalveolar lavage), lung pa-
renchyma, pleural cavity lavage, mediastinal lymph nodes 
(MLNs), and spleens. Cells derived from each donor and 
from the host were distinguished on the basis of CD90 and 
CD45 expression, and the ratio of the response of the two 
donors was determined (39). An example of the sorting/
transfer strategy and the data generated is presented in Fig. 4. 
The strength of this basic approach is that the response of 
two polyclonal (i.e., nontransgenic) populations of cells 
is compared in the same animal under identical infection 
conditions. In addition, it eff  ectively integrates all of the 
factors involved in the accumulation of activated eff  ector 
T cells at the site of infection, such as their capacity to migrate 
to lymph nodes before infection, the overall proliferative and 
death rates of the responding cells, and the capacity of the 
cells to migrate to infl  ammatory sites (27). As shown in Fig. 5, 
data obtained from several experiments established that 
CD43lo memory CD8+ T cells were two- to fi  vefold more 
effi   cient than CD43hi cells at mediating the recall response 
to Sendai virus infection in the airways, parenchyma, and 
pleural cavities of the lung (similar data were obtained in the 
MLN and spleen; not depicted). This relative dominance 
of the CD43lo subpopulation was observed regardless of 
whether the memory T cells were isolated 1 or 6 mo after 
the primary infection (Fig. 5). These data support the fi  nding 
that CD43lo memory CD8+ T cells mediate stronger recall 
responses than CD43hi cells in terms of their accumulation at 
the site of infection, and this dominance is maintained over 
the long term.
Using the same approach, we then compared the recall 
effi   cacy of CD27hi and CD27lo, as well as CXCR3hi and 
CXCR3lo, memory subpopulations. As shown in Fig. 5, 
data from several independent experiments showed that the 
CD27hi and CXCR3hi memory subpopulations were 2–10-fold 
more effi   cient than their counterparts at contributing to the 
recall responses in diff  erent compartments of the lung. In the 
case of CXCR3 sorted cells, we also analyzed the phenotype 
of eff  ector CD8+ T cells that accumulated in the lungs of host 
mice on day 10 of infection. Donor memory cells retained 
their original CXCR3 phenotype in both the lung and spleen 
(not depicted), suggesting that expression of this chemokine 
receptor is not necessary for memory cell activation or mi-
gration into a site of infl  ammation. The original phenotypic 
Figure 4.  Recall effi  cacy of CD43hi and CD43lo memory T cells. 
Donor mice (CD45.2/CD90.2 and CD45.1/CD90.2) were infected with 
Sendai virus and splenocytes isolated 1 mo later. Cells were enriched for 
CD8+ cells on negative selection columns and then sorted into CD44hi/
CD43hi and CD44hi/CD43lo subpopulations by FACS. Sorted subsets were 
combined from each donor, such that the number of Sendai NP324–332/Kb+ 
cells derived from each donor was equivalent (usually 10,000 tetramer+ 
cells comprised of 5,000 cells from each donor) and intravenously trans-
ferred into recipient mice (CD45.2/CD90.1). 1 d after transfer, the recipient 
mice were then intranasally challenged with Sendai virus, and the indi-
cated tissues were analyzed 11 d later. The fl  ow cytometric profi  les in the 
bottom rows of each panel are gated on tetramer+/CD8+ cells (indicated 
in the oval gate in the top panels). The data are representative from two 
recipient mice.1630  RECALL EFFICACY OF MEMORY CD8 T CELLS | Hikono et al.
pattern was also retained through day 35 after transfer (day 34 
after infection), when the donor cells had returned to a rest-
ing memory phenotype (Fig. 6, A and B). Furthermore, the 
CXCR3lo cells retained their original CD127lo and CD43lo 
phenotype when analyzed at this time point. However, re-
tention of the original phenotype by eff  ector– or secondary 
memory CD8+ T cells was not characteristic of cells sorted 
on the basis of CD43 expression inasmuch as each of the 
CXCR3hi/CD43hi and CXCR3hi/CD43lo subpopulations 
was capable of generating all three of the memory T cell 
subpopulations after reactivation (not depicted). Collectively, 
the data suggest that memory CD8+ T cells expressing ei-
ther a CD27hi, CXCR3hi, or a CD43lo phenotype mediate 
the strongest recall response. Furthermore, cells expressing 
either a CXCR3hi or CXCR3lo phenotype retain this pheno-
type throughout the response and into the establishment of 
secondary memory cells. However, it is currently unclear 
whether this phenotype is retained over the long term.
CD27hi/CD43lo memory CD8+ T cells mediate 
the strongest recall response in the lung
The data thus far indicate that memory CD8+ T cells with ei-
ther a CD27hi or a CD43lo phenotype mounted superior recall 
responses. Collectively, these data suggest that the CD27hi/
CD43lo memory CD8+ T cell subpopulation mounted the 
strongest recall response in the lung. To test this idea, we 
sorted memory CD8+ T cells from the spleens of mice that 
had recovered from a prior Sendai virus infection (1 mo af-
ter infection) into the three memory T cells subpopulations 
and used dual adoptive transfer studies to compare the ability 
of each subpopulation to mount a recall response (the sort-
ing strategy is illustrated in Fig. S1, available at http://www
.jem.org/cgi/content/full/jem.20070322/DC1). Because 
CXCR3 and CD27 are coordinately expressed (Fig. 1 and not 
depicted), the anti-CXCR3 antibody, rather than the anti-
CD27 antibody, was used for sorting as it yielded superior 
separation of the memory cell subsets. These three-way sort/dual 
Figure 5.  Memory CD8+ T cell subpopulations differ in their 
capacity to mediate recall responses. Splenic CD8+ T cells were isolated 
at 1 mo after infection (and additionally at 6 mo after infection for CD43 
only) and fl  ow cytometrically sorted into CD43hi/lo, CD27hi/lo, or CXCR3hi/lo 
subpopulations. The cells were then tested for their capacity to contribute 
to a recall response to intranasal Sendai virus challenge using the strat-
egy outlined in Fig. 4. The relative response in each tissue was calculated 
as the percentage of Sendai NP324–332/Kb-specifi  c T cells derived from one 
donor population divided by the percentage from the second donor popu-
lation (i.e., the ratio of donor cell populations recruited to the tissue). 
Each symbol represents data from an individual recipient mouse. Data are 
from four independent experiments for CD43 (1 and 6 mo after infection) 
and CD27 and six independent experiments for CXCR3. Pleural cavity 
lavages were not collected in all of the CXCR3 experiments.
Figure 6.  Activation marker phenotype is retained on secondary 
memory CD8+ T cells. Mice from the dual adoptive transfer of CXCR3+ 
and CXCR3− memory CD44+/CD8+ T cells in Fig. 5 were analyzed on day 
34 after infection. Spleens were harvested, and the expression of CXCR3, 
CD127, CD43, and CD62L was analyzed on tetramer+/CD8+ gated cells 
from the host (1° memory) and each of the transferred populations 
(CXCR3+ 2° memory and CXCR3− 2° memory). Representative staining 
from one mouse is shown in A. (B) Cumulative data from independent 
transfer experiments. Each symbol represents an individual mouse. The 
data are representative of three independent experiments.JEM VOL. 204, July 9, 2007  1631
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adoptive transfer experiments clearly demonstrate that the 
three CXCR3hi/CD43hi, CXCR3hi/CD43lo, and CXCR3lo/
CD43lo memory cell subpopulations diff  er in their capacity 
to mount recall responses in the lungs after secondary Sendai   
virus challenge (Fig. 7). CXCR3hi/CD43lo cells (labeled as 
population A in Fig. 7) were superior to both CXCR3lo/
CD43lo cells (labeled as population B) and CXCR3hi/CD43hi 
cells (labeled as population C). Furthermore, CXCR3lo/CD43lo 
cells (population B) mounted the weakest recall response 
compared with the other two memory T cell populations. 
These data, together with the fact that CXCR3 and CD27 
are coordinately expressed, support a hierarchy of CD27hi/
CD43lo > CD27hi/CD43hi > CD27lo/CD43lo memory cells 
in terms of mediating recall responses in the lung.
Vaccination elicits different subpopulations 
of memory CD8+ T cells
The diff  erences in recall effi   cacy of memory CD8+ T cell 
subpopulations have substantial implications for the design 
of vaccines. Therefore, we compared the capacity of Sendai 
NP324–332 peptide-loaded dendritic cells or peptide adminis-
tered in CFA to elicit memory CD8+ T cells. In the course of 
these analyses, we observed that Sendai NP324–332 peptide/CFA 
induced very high frequencies of CD27lo/CD43lo memory 
CD8+ T cells, predicted by our previous analysis to be poor 
responders to secondary Sendai virus challenge (Fig. 8 A). Al-
though the ratio of the three CD27hi/CD43lo, CD27hi/CD43hi, 
and CD27lo/CD43lo memory CD8+ T cell subpopulations 
was  1:1:1 in mice that had recovered from a prior Sendai 
virus infection (1 mo after infection), the ratio of these sub-
populations was  1:2:6 in peptide/CFA-vaccinated mice. 
Also, a substantial population of cells with a fourth phenotype 
(CD27lo/CD43hi) was observed in peptide CFA-vaccinated 
mice. In addition, the memory T cell pool elicited by peptide 
CFA vaccination was exclusively of the effector–memory 
phenotype, and  90% of the cells were CD127hi (Fig. 8 B). 
Consistent with data generated from mice that had recovered 
from a Sendai virus infection, KLRG1+ cells were highly en-
riched among the CD27lo subpopulations of memory T cells 
elicited by peptide CFA vaccination (Fig. 8 C). Because 
CD27lo cells represented a greater proportion of the memory 
pool generated by CFA vaccination (compared with viral 
infection), a much higher frequency of the total NP324–332/Kb-
specifi  c population was also KLRG1+ (Fig. 8 D).
Based on these fi  ndings, we hypothesized that the overall 
pool of NP324–332/Kb-specifi  c memory T cells generated by 
NP324–332 peptide/CFA vaccination would mount weaker 
recall responses compared with the pool of NP324–332/Kb-
specifi  c memory T cells generated by a prior Sendai virus 
infection. Because peptide/CFA vaccination induced suffi   -
cient numbers of memory T cells available for dual transfer 
studies, we were able to test this hypothesis by directly com-
paring the recall effi   cacy of memory T cells isolated from 
vaccinated mice to those isolated from mice that had recov-
ered from a prior Sendai virus infection. As shown in Fig. 9 A, 
data from several experiments demonstrated that memory 
CD8+ T cells from peptide/CFA-vaccinated mice were 
10-fold less effi   cient than memory cells from Sendai virus–
infected mice at contributing to a recall response to Sendai 
virus infection in the lung airways and parenchyma (similar 
data were obtained in the MLN and spleen; not depicted). 
Thus, consistent with our phenotypic analyses and our hypo-
thesis, peptide/CFA vaccination generated comparatively poor 
quality memory T cells.
To investigate the memory CD8+ T cells generated by 
peptide/CFA vaccination further, we isolated memory sub-
populations on the basis of CD43hi/CD43lo or CXCR3hi/
CXCR3lo expression and compared their abilities to contribute 
to the recall response to intranasal Sendai virus infection. Con-
sistent with memory cells generated by Sendai virus infection, 
CXCR3hi cells were superior to CXCR3lo cells in mounting 
Figure 7.  CD43lo/CXCR3hi memory CD8+ T cell subset mediates 
the strongest recall responses. Donor mice (CD45.2/CD90.2 and CD45.1/
CD90.2) were infected with Sendai virus. 1 mo later, splenocytes were 
enriched for CD8+ cells using negative selection columns and fl  ow cyto-
metrically sorted into CD44hi/CD43lo/CXCR3hi (subpopulation A), CD44hi/
CD43lo/CXCR3lo (subpopulation B), and CD44hi/CD43hi/CXCR3hi (subpopu-
lation C) as illustrated in the schematic and using the strategy outlined in 
Fig. S1. Cells were then tested pair wise in dual adoptive transfer experi-
ments for their capacity to contribute to a recall responses to intranasal 
Sendai virus challenge, as described in the legends to Figs. 4 and 5. Each 
symbol represents data from an individual recipient mouse, and the data 
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recall responses (Fig. 9 B). Interestingly, CD43hi cells resulting 
from peptide/CFA-vaccinated mice were superior to CD43lo 
cells, a fi  nding opposite to that seen with memory cells gen-
erated by Sendai virus infection. However, this diff  erence is 
fully consistent with the fact that CD43lo cells isolated from 
peptide/CFA-vaccinated mice are dominated by poorly re-
sponsive CXCR3lo/CD43lo cells (Fig. 8 A). In summary, the 
distribution of distinct memory CD8+ T cell subpopulations 
generated by vaccination or infection can accurately forecast 
the recall potential of the memory T cell pool.
DISCUSSION
Despite progress over the last few years in characterizing the 
properties of memory T cells, it is still not understood how 
diff  erent types of memory T cells actually contribute to recall 
responses or which memory T cells are the most appropriate 
for diff  erent pathogens. A key advance has been the realiza-
tion that memory cells express distinct patterns of homing 
receptors. This in turn has led to the idea that eff  ector–memory 
T cells in the periphery play a key role in mediating immedi-
ate responses to mucosal or peripheral infections, whereas 
central–memory T cells are more important for mediating 
proliferative responses to systemic infections. However, this 
idea has been diffi   cult to reconcile with data showing that 
both central– and eff  ector–memory T cells mount potent 
proliferative responses (16, 21–26, 28). In this study, we have 
analyzed T cell memory subpopulations from the perspective 
of activation markers. The data indicate that patterns of CD27 
and CD43 (1B11) expression defi  ne three distinct subpop-
ulations of memory CD8+ T cells that diff  er signifi  cantly 
in their capacities to contribute to the accumulation of eff  ec-
tor cells in the lungs during a respiratory virus challenge. 
These subpopulations coordinately express an array of other 
markers associated with activation status, including CXCR3, 
CD127, and KLRG1, and are independent of eff  ector– and 
central–memory status (23, 31, 34, 40). In general, there ap-
pears to be an inverse correlation between activation status 
and proliferative potential, such that cells with the most 
“rested” phenotype have the capacity to mediate the stron-
gest recall responses. For example, the subpopulation of 
memory T cells able to mediate the strongest recall response 
was shown to express a CD27hi/CD43lo phenotype (41). In 
contrast, the subpopulation of memory T cells that mediated 
the weakest recall responses expressed a CD27lo/CD43lo 
phenotype. Indeed many, but not all, of the cells in this latter 
subpopulation expressed characteristics of senescent T cells, 
including expression of KLRG1. Although all of the sub-
populations of memory cells are based on markers typically 
associated with activation, the cells are nevertheless small, 
nonblasted, and do not express acute activation markers such 
as CD69 or CD25. Thus, our data support a new functional 
Figure 8.  Memory CD8+ T cells generated by peptide/CFA vacci-
nation are enriched for cells with a poorly proliferative phenotype. 
Mice were either intranasally infected with Sendai virus or subcutane-
ously vaccinated with Sendai NP324–332 peptide/CFA and analyzed 1 mo 
later. (A) Phenotype of tetramer+/CD8+ cells based on the expression of 
CD27 and CD43 (left) or CXCR3 and CD43 (right) in Sendai virus–immune 
mice (top panels) or peptide/CFA-vaccinated mice (bottom panels). Each 
subpopulation is indicated by the shading pattern in the schematic 
under the bar charts. The data show the means ± SD of three individual 
mice. (B) Coexpression of CD43, CD62L, CD27, CXCR3, and CD127 on 
tetramer+/CD8+ gated cells from NP324–332/CFA-vaccinated mice 1 mo after 
vaccination. Numbers represent the percentage of cells in each quadrant. 
The data are representative of three individual mice. (C) Splenocytes from 
peptide/CFA-vaccinated mice were gated on tetramer+/CD8+ cells and 
divided into subsets based on the expression of CD27 and CD43. The fre-
quency of KLRG1+ cells within each subset is plotted for individual mice. 
(D) The frequency of KLRG1+ cells among total Sendai NP324–332/Kb+ cells 
after peptide/CFA vaccination or Sendai virus infection are plotted for 
individual mice. The data for C and D are combined from two indepen-
dent experiments. JEM VOL. 204, July 9, 2007  1633
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classifi  cation of memory CD8+ T cells that is based on activa-
tion phenotype rather than the widely accepted central– and 
eff  ector–memory T cell classifi  cation (based on markers such 
as CD62L and CCR7). The most potent memory T cells, in 
terms of their proliferative capacity, express the most quies-
cent activation phenotype, and these cells tend to accumulate 
over time. This population also becomes increasingly domi-
nated by cells with a central–memory phenotype (CD62Lhi) 
and ultimately comes to most resemble naive T cells. Overall, 
these fi  ndings suggest a pattern of memory T cell diff  erentia-
tion in which many markers and properties change over time, 
but at diff  erent rates.
The division of memory cells into subpopulations based 
on the expression of activation markers may help explain 
certain features of CD8+ T cell memory. First, we have 
previously shown that the recall effi   cacy of memory CD8+ 
T cells progressively improves over time (28). This observa-
tion could not be explained by changes in the distribution 
of eff  ector– and central–memory T cells over time, as the 
improvement occurred on a per-cell basis and within both 
of these subpopulations. However, the data here show that 
there is a progressive loss of memory cell subpopulations that 
express a weak (CD27lo/CD43lo) or intermediate (CD27hi/
CD43hi) proliferative capacity from the total memory T cell 
pool. Although these less responsive phenotypes of cells rep-
resented  70% of the total memory T cell pool at 1 mo 
after infection, they only represented 5–10% of the popula-
tion at 2 yr after infection (with the very poorly responding 
CD27lo/CD43lo subpopulation essentially gone by about 1 yr 
after infection). Thus, a progressive loss of poorly responding 
memory T cells may explain the fi  nding that that effi   cacy of 
the total memory T cell pool increases over time. Second, 
we have previously shown that the relative contributions of 
eff  ector– and central–memory T cell subpopulations to re-
call responses diff  er dramatically between recently generated 
and long-term pools of memory T cells (28, 29). Changes 
in the distribution of memory cells expressing activation 
markers within these subpopulations over time potentially 
explain these diff  erences. For example, the strongly respon-
sive CD27hi/CD43lo cells become increasingly represented in 
central–memory cells over time (for example, compare the 
distribution of CD43hi and CD43lo cells in the central– and 
eff  ector–memory T cell pools at 1 and 12 mo after infection 
in Fig. 1). Third, our unpublished studies had suggested that 
although peptide/CFA vaccination was eff  ective at establish-
ing large numbers of memory T cells, it was relatively poor 
at eliciting recall responses. Our current observation that 
peptide/CFA vaccination generated very high frequencies 
of poorly responsive CD27lo/CD43lo memory CD8+ T cells 
likely explains the overall weak recall response elicited by this 
vaccine strategy. Thus, enumeration of these newly described 
memory CD8+ T cell subpopulations allows one to predict 
the overall effi   cacy of a recall response.
 The signifi   cance of the CD27 and CD43 activation 
markers on memory T cells is poorly understood. CD27 is 
a TNF receptor family member that functions as a T and 
B cell costimulatory molecule (32, 42, 43). This marker has 
previously been shown to correlate with eff  ector functions 
in humans (44). CD43 occurs as two distinct glycoforms 
(115 and 130 kD) of which the 130 kD glycoform is associ-
ated with T cell activation and is specifi  cally detected by the 
1B11 antibody (45). It is involved in cell adhesion and may 
also regulate apoptosis during acute and memory phases of 
an immune response (33, 46–48). Although these markers 
clearly regulate diff  erent aspects of the immune response, it 
is unlikely that they actually mediate the diff  erences in recall 
response observed in the current studies. Rather, they are 
probably surrogate markers of intrinsic programmed states of 
the memory T cell that aff  ects recall effi   cacy. One possibility 
is that this phenotype is associated with optimal access to sites 
of antigen presentation within lymphoid tissues, although this 
is not entirely consistent with patterns of CD62L expression 
(27). Another possibility is that these cells may have under-
gone less expansion during the acute response and therefore 
retain more proliferative potential (49). We are currently in-
vestigating these possibilities.
The lack of any relationships between activation marker 
status and central/eff  ector–memory phenotypes suggests that 
Figure 9.  Memory CD8+ T cells generated by peptide/CFA vaccina-
tion exhibit poor recall effi  cacy. (A) Recall effi  cacy of memory CD8+ 
T cells generated by Sendai virus infection and peptide/CFA vaccination. 
C57BL/6 donor mice were subcutaneously vaccinated with Sendai virus 
nucleoprotein peptide (NP324–332) emulsifi  ed in CFA, and CD90.1 donor 
mice were intranasally infected with Sendai virus. 1 mo later, splenic 
CD8+/CD44hi memory cells were isolated and analyzed in dual adoptive 
transfer experiments for their capacity to contribute to recall responses to 
intranasal Sendai virus challenge, as described in the legend to Figs. 4 and 5. 
Each symbol represents data from an individual recipient mouse, and 
the data are derived from three independent experiments. (B) Comparison 
of the relative responses of memory CD8+ T cell subpopulations elicited 
by peptide/CFA vaccination. Mice were vaccinated or infected as described 
for A, and CD8+ enriched cells were sorted into CD44hi/CD43hi and CD44hi/
CD43lo (or CD44hi/CXCR3hi and CD44hi/CXCR3lo) by FACS. The sorted sub-
sets were then compared by dual adoptive transfer as described for A. 
Each symbol represents data from an individual recipient mouse, and two 
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these two characteristics of memory T cells are completely 
independent of each other. Several studies have addressed the 
relative recall effi   cacy of central– and eff  ector–memory T cells, 
and results from these studies have been either contradictory 
or inconclusive, probably refl  ecting the use of diff  erent infec-
tion models (16, 21–28). Also, these studies did not account 
for the presence of KLRG1-expressing senescent cells within 
the populations of memory T cells examined (as discussed 
above; reference 34). Other issues to be considered are the 
migration and resulting distribution of the cells in adoptive 
transfer experiments. Cells separated on the basis of CD62L 
tend to distribute diff  erently in recipients after adoptive trans-
fer with CD62Lhi cells tending to localize preferentially in the 
lymph nodes (28, 29). An ability to localize the lymph nodes 
is likely important for responses that depend on dendritic cell 
and antigen traffi   cking to the lymph nodes (27). In these cur-
rent studies, we found no evidence that memory CD8+ 
T cells expressing diff  erent activation markers had diff  erent 
patterns of migration to the lymph nodes (unpublished data). 
These data further suggest that activation markers (CD27/
CD43) and migration markers (CD62L/CCR7) defi  ne dis-
tinct, and unrelated, characteristics of memory cells. Thus, 
activation marker expression may infl  uence the general ca-
pacity of memory T cells to mediate a recall response, whereas 
migration markers may dictate the capacity of memory T 
cells to migrate to sites of antigen deposition.
In summary, the data presented here suggest that the expres-
sion of certain activation markers on memory CD8+ T cells is 
a better predictor of recall effi   cacy than central– and eff  ector–
memory phenotype. Separation of memory cell subpopulations 
by these phenotypes helps resolve prior discrepancies regarding 
the contribution of central– and eff  ector–memory T cells to re-
call responses, and also supports the use of these phenotypes as 
an alternative or additional scheme to classify memory T cells. 
Although central– and eff  ector–memory phenotypes are mark-
ers of memory T cell–traffi   cking patterns, activation marker ex-
pression likely indicates diff  erent functional qualities of memory 
T cells. Clearly, both factors need to be taken into consideration 
during vaccine development.
MATERIALS AND METHODS
Virus, mice, infection, and vaccination. Sendai virus (Enders strain) and 
infl  uenza virus A/HK-x31 were grown, stored, and titered as described 
previously (50). 8–12-wk-old female C57BL/6J, B6.SJL-Ptprca Pep3/BoyJ 
(CD45.1), and B6.Pl-Thy1a/Cy (CD90.1) mice (The Jackson Laboratory) 
were anesthetized and intranasally infected with 250 50% egg infectious 
doses (EID50) of Sendai virus or 600 EID50 of x31 infl  uenza virus. Vaccina-
tion was performed with 50 μg of Sendai virus nucleoprotein peptide 
(NP324–332) emulsifi  ed in 100 μl CFA by subcutaneous injection in the base 
of the tail. All animal studies were approved by the Trudeau Institute Animal 
Care and Use Committee.
Flow cytometric analyses. Splenocytes were panned on goat anti–mouse 
IgG H+L (Jackson ImmunoResearch Laboratories) -coated fl  asks and stained 
with APC-conjugated tetramers (Sendai NP324–332/Kb, Flu NP366-374/Db, or 
Flu PA224-233/Db) and antibodies to cell surface markers (CD8, CD44, CD43 
[1B11], CD62L, CD27, CXCR3, CD127, KLRG1, or PD-1). Samples were 
run on FACSCalibur (BD Biosciences) or CyAn ADP (DakoCytomation) 
fl  ow cytometers. Data were analyzed using FlowJo software (Tree Star).
Intracellular BrdU staining. BrdU staining was performed as described 
previously (51). Mice were administered 0.8 mg/ml BrdU in the drink-
ing water for 14 d. Splenocytes were then stained as described above and 
fi  xed overnight at 4°C in 1% paraformaldehyde/PBS containing 0.05% 
Nonidet P-40. After washing, cellular DNA was denatured with DNase I 
(bovine pancreas; Sigma-Aldrich). Cells were subsequently stained with anti–
BrdU-FITC.
Intracellular cytokine and granzyme B staining. Sorted memory 
CD8+ T cell subsets were co-cultured at 37°C for 5 h with naive CD45.1+ 
splenocytes pulsed with 1 μg of Sendai NP324–332 peptide in 250 μl of 
CTM containing 10 μg/ml brefeldin A (Epicenter Biotechnologies) and 
10 U/ml IL-2 (R&D Systems). After culture, the cells were stained with 
anti-CD8 and anti-CD45.2 in PBS/brefeldin A. The cells were then fi  xed 
in 2% formaldehyde, permeabilized with buff  er containing 0.5% saponin, 
and stained with either anti–IFN-γ, anti–TNF-α, or anti–IL-2 monoclo-
nal antibodies conjugated to APC (BD Biosciences). For granzyme B stain-
ing, cells were fi  xed and permeabilized using the Cytofi  x/Cytoperm kit 
(BD Biosciences) after tetramer and surface marker staining. Cells were 
stained with anti–granzyme B or isotype control antibody conjugated to 
PE (Caltag Laboratories).
Isolation of memory CD8+ T cell subpopulations by FACS. Lym-
phocytes were isolated from spleens and further enriched for CD8+ cells 
using negative selection T cell enrichment columns (R&D Systems). In 
two-way sorting, enriched CD8+ cells were stained with anti–CD44-FITC 
and either anti–CD43 (1B11)-PE, anti–CD27-PE, or anti–CXCR3-PE. 
CD44hi cells were sorted into two subsets based on the expression of 
the other cell surface marker; e.g., CD44hiCD43hi and CD44hiCD43lo. In 
three-way sorting, enriched CD8+ cells were stained with anti–CD44-
APC-AF750 and anti–CD43 (1B11)-AF488 in combination with either 
anti–CXCR3-PE or anti–CD27-PE. CD44hi cells were sorted into three 
subsets based on the expression of CD43 and the other cell surface marker; e.g., 
CD44hiCD43loCXCR3hi, CD44hiCD43loCXCR3lo, and CD44hiCD43hi
CXCR3hi (Fig. S1). Sorting was performed on a FACSVantage cell sorter 
with DIVA enhancement software (BD Biosciences).
Dual adoptive transfer of memory subsets. Dual adoptive transfer ex-
periments were performed as described previously (28, 29). In brief, memory 
subsets from the donors were combined such that the number of Sendai 
NP324–332/Kb-specifi  c T cells in each donor population was equal. The com-
bined cell subsets were intravenously transferred into naive recipients and 
then intranasally challenged with 250 EID50 of Sendai virus 1 d later. On day 
11 after infection, lymphocytes were isolated from various tissues, stained 
with Sendai NP324–332/Kb tetramer-APC, anti–CD8-PerCP, anti–CD45.1-
FITC, and anti–CD90.2-PE, and then analyzed by fl  ow cytometry. The rel-
ative response in each tissue was calculated from the numbers of Sendai 
NP324–332/Kb-specifi  c T cells derived from each donor. Control experiments 
demonstrated that neither anti-CD43 (1B11), anti-CD27, nor anti-CXCR3 
monoclonal antibody staining negatively aff  ected the ability of donor cells to 
mount a recall response in vivo.
Online supplemental material. An example of the sorting strategy used 
to isolate memory CD8+ T cell subsets for functional studies is shown 
in Fig. S1, which is available at http://www.jem.org/cgi/content/full/
jem.20070322/DC1.
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